Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1355 6037 OR L773:1468 201X "

Sökning: L773:1355 6037 OR L773:1468 201X

Sortera/gruppera träfflistan
  • Adielsson, A, et al. (författare)
  • Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia : bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective
  • 2011
  • Ingår i: Heart. - : B M J Group. - 1355-6037 .- 1468-201X. ; 97:17, s. 1391-1396
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives In a national perspective, to describe survival among patients found in ventricular fibrillation or pulseless ventricular tachycardia witnessed by a bystander and with a presumed cardiac aetiology and answer two principal questions: (1) what are the changes over time? and (2) which are the factors of importance? Design Observational register study. Setting Sweden. Patients All patients included in the Swedish Out of Hospital Cardiac Arrest Register between 1 January 1990 and 31 December 2009 who were found in bystander-witnessed ventricular fibrillation with a presumed cardiac aetiology. Interventions Bystander cardiopulmonary resuscitation (CPR) and defibrillation. Main outcome measures Survival to 1 month. Results In all, 7187 patients fulfilled the set criteria. Age, place of out-of-hospital cardiac arrest (OHCA) and gender did not change. Bystander CPR increased from 46% to 73%; 95% CI for OR 1.060 to 1.081 per year. The median delay from collapse to defibrillation increased from 12 min to 14 min (p for trend 0.0004). Early survival increased from 28% to 45% (95% CI 1.044 to 1.065) and survival to 1 month increased from 12% to 23% (95% CI 1.058 to 1.086). Strong predictors of early and late survival were a short interval from collapse to defibrillation, bystander CPR, female gender and OHCA outside the home. Conclusion In a long-term perspective in Sweden, survival to 1 month after ventricular fibrillation almost doubled. This was associated with a marked increase in bystander CPR. Strong predictors of outcome were a short delay to defibrillation, bystander CPR, female gender and place of collapse.
  • Alfredsson, Joakim, et al. (författare)
  • Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
  • 2017
  • Ingår i: Heart. - : BMJ PUBLISHING GROUP. - 1355-6037 .- 1468-201X. ; 103:15, s. 1168-1176
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives Dual antiplatelet therapy (DAPT) with aspirin + a P2Y12 inhibitor is recommended for at least 12 months for patients with acute coronary syndrome (ACS), with shorter durations considered for patients with increased bleeding risk. However, there are no decision support tools available to predict an individual patients bleeding risk during DAPT treatment in the post-ACS setting. Methods To develop a longitudinal bleeding risk prediction model, we analysed 9240 patients with unstable angina/non-ST segment elevation myocardial infarction (NSTEMI) from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial, who were managed without revascularisation and treated with DAPT for a median of 14.8 months. Results We identified 10 significant baseline predictors of non-coronary artery bypass grafting (CABG)-related Global Use of Strategies to Open Occluded Arteries (GUSTO) severe/life-threatening/moderate bleeding: age, sex, weight, NSTEMI (vs unstable angina), angiography performed before randomisation, prior peptic ulcer disease, creatinine, systolic blood pressure, haemoglobin and treatment with beta-blocker. The five significant baseline predictors of Thrombolysis In Myocardial Infarction (TIMI) major or minor bleeding included age, sex, angiography performed before randomisation, creatinine and haemoglobin. The models showed good predictive accuracy with Therneaus C-indices: 0.78 (SE=0.024) for the GUSTO model and 0.67 (SE=0.023) for the TIMI model. Internal validation with bootstrapping gave similar C-indices of 0.77 and 0.65, respectively. External validation demonstrated an attenuated C-index for the GUSTO model (0.69) but not the TIMI model (0.68). Conclusions Longitudinal bleeding risks during treatment with DAPT in patients with ACS can be reliably predicted using selected baseline characteristics. The TRILOGY ACS bleeding models can inform riskbenefit considerations regarding the duration of DAPT following ACS.
  • Bahit, M. Cecilia, et al. (författare)
  • Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
  • 2017
  • Ingår i: Heart. - 1355-6037 .- 1468-201X. ; 103:8, s. 623-628
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective We describe the incidence, location and management of non-major bleeding, and assess the association between non-major bleeding and clinical outcomes in patients with atrial fibrillation (AF) receiving anticoagulation therapy enrolled in Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE). Methods We included patients who received >= 1 dose of study drug (n= 18 140). Non-major bleeding was defined as the first bleeding event considered to be clinically relevant non-major (CRNM) or minor bleeding, and not preceded by a major bleeding event. Results Non-major bleeding was three times more common than major bleeding (12.1% vs 3.8%). Like major bleeding, non-major bleeding was less frequent with apixaban (6.4 per 100 patient-years) than warfarin (9.4 per 100 patient-years) (adjusted HR 0.69, 95% CI 0.63 to 0.75). The most frequent sites of non-major bleeding were haematuria (16.4%), epistaxis (14.8%), gastrointestinal (13.3%), haematoma (11.5%) and bruising/ecchymosis (10.1%). Medical or surgical intervention was similar among patients with non-major bleeding on warfarin versus apixaban (24.7% vs 24.5%). A change in antithrombotic therapy (58.6% vs 50.0%) and permanent study drug discontinuation (5.1% (61) vs 3.6% (30), p=0.10) was numerically higher with warfarin than apixaban. CRNM bleeding was independently associated with an increased risk of overall death (adjusted HR 1.70, 95% CI 1.32 to 2.18) and subsequent major bleeding (adjusted HR 2.18, 95% CI 1.56 to 3.04). Conclusions In ARISTOTLE, non-major bleeding was common and substantially less frequent with apixaban than with warfarin. CRNM bleeding was independently associated with a higher risk of death and subsequent major bleeding. Our results highlight the importance of any severity of bleeding in patients with AF treated with anticoagulation therapy and suggest that non-major bleeding, including minor bleeding, might not be minor.
  • Baron, Tomasz, et al. (författare)
  • Type 2 myocardial infarction in clinical practice.
  • 2015
  • Ingår i: Heart. - : BMJ Publishing Group. - 1355-6037 .- 1468-201X. ; 101:2, s. 101-106
  • Tidskriftsartikel (refereegranskat)abstract
    • We aimed to assess differences in incidence, clinical features, current treatment strategies and outcome in patients with type 2 vs. type 1 acute myocardial infarction (AMI).
  • Bergh, Cecilia, 1972-, et al. (författare)
  • Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age
  • 2015
  • Ingår i: Heart. - : BMJ Publishing Group Ltd. - 1355-6037 .- 1468-201X. ; 101:8, s. 623-629
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: Psychosocial stress is a suggested risk for coronary heart disease (CHD). The relationship of stress resilience in adolescence with subsequent CHD risk is underinvestigated, so our objective was to assess this and investigate the possible mediating role of physical fitness.METHODS: In this register-based study, 237 980 men born between 1952 and 1956 were followed from 1987 to 2010 using information from Swedish registers. Stress resilience was measured at a compulsory military conscription examination using a semistructured interview with a psychologist. Some 10 581 diagnoses of CHD were identified. Cox regression estimated the association of stress resilience with CHD, with adjustment for established cardiovascular risk factors.RESULTS: Low-stress resilience was associated with increased CHD risk. The association remained after adjustment for physical fitness and other potential confounding and mediating factors, with adjusted HRs (and 95% CIs) of 1.17 (1.10 to 1.25), with some evidence of mediation by physical fitness. CHD incidence rates per 1000 person-years (and 95% CIs) for low-stress, medium-stress and high-stress resilience were 2.61 (2.52 to 2.70), 1.97 (1.92 to 2.03) and 1.59 (1.53 to 1.67) respectively. Higher physical fitness was inversely associated with CHD risk; however, this was attenuated by low-stress resilience, shown by interaction testing (p<0.001).CONCLUSIONS: Low-stress resilience in adolescence was associated with increased risk of CHD in middle age and may diminish the benefit of physical fitness. This represents new evidence of the role of stress resilience in determining risk of CHD and its interrelationship with physical fitness.
  • Berglund, Elisabeth, et al. (författare)
  • High incidence of infective endocarditis in adults with congenital ventricular septal defect
  • 2016
  • Ingår i: Heart. - : BMJ Publishing Group. - 1355-6037 .- 1468-201X. ; 102:22, s. 1835-1839
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective Ventricular septal defects (VSDs), if haemodynamically important, are closed whereas small shunts are left without intervention. The long-term prognosis in congenital VSD is good but patients are still at risk for long-term complications. The aim of this study was to clarify the incidence of infective endocarditis (IE) in adults with VSD. Methods The Swedish registry for congenital heart disease (SWEDCON) was searched for adults with VSD. 779 patients were identified, 531 with small shunts and 248 who had the VSD previously closed. The National Patient Register was then searched for hospitalisations due to IE in adults during a 10-year period. Results Sixteen (2%) patients were treated for IE, 6 men and 10 women, with a mean age of 46.3 ±12.2 years. The incidence of IE was 1.7-2.7/1000 years in patients without previous intervention, 20-30 times the risk in the general population. Thirteen had small shunts without previous intervention. There was no mortality in these 13 cases. Two patients had undergone repair of their VSD and also aortic valve replacement before the episode of endocarditis and a third patient with repaired VSD had a bicuspid aortic valve, all of these three patients needed reoperation because of their IE and one patient died. No patient with isolated and operated VSD was diagnosed with IE. Conclusions A small unoperated VSD in adults carries a substantially increased risk of IE but is associated with a low risk of mortality.
  • Carlsson, Axel C, et al. (författare)
  • Neighbourhood socioeconomic status and coronary heart disease in individuals between 40 and 50 years.
  • 2016
  • Ingår i: Heart. - : BMJ Publishing Group. - 1355-6037 .- 1468-201X. ; 102:10
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: The incidence of myocardial infarction (MI) has decreased in general but not among younger middle-aged adults. We performed a cohort study of the association between neighbourhood socioeconomic status (SES) at the age of 40 and risk of MI before the age of 50 years. METHODS: All individuals in Sweden were included in the year of their 40th birthday, if it occurred between 1998 and 2010. National registers were used to categorise neighbourhood SES into high, middle and low, and to retrieve information on incident MI and coronary heart disease (CHD). Cox regression models, adjusted for marital status, education level, immigrant status and region of residence, provided an estimate of the HRs and 95% CIs for MI or CHD. RESULTS: Out of 587 933 men and 563 719 women, incident MI occurred in 2877 (0.48%) men and 932 (0.17%) women; and CHD occurred in 4400 (0.74%) men and 1756 (0.31%) women during a mean follow-up of 5.5 years. Using individuals living in middle-SES neighbourhoods as referents, living in high-SES neighbourhoods was associated with lower risk of MI in both sexes (HR (95% CI): men: 0.72 (0.64 to 0.82), women: 0.66 (0.53 to 0.81)); living in low-SES neighbourhoods was associated with a higher risk of MI (HR (95% CI): men: 1.31 (1.20 to 1.44), women: 1.28 (1.08 to 1.50)). Similar risk estimates for CHD were found. CONCLUSIONS: The results of our study suggest an increased risk of MI and CHD among residents from low-SES neighbourhoods and a lower risk in those from high-SES neighbourhoods compared with residents in middle-SES neighbourhoods.
  • Christersson, Christina, et al. (författare)
  • Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
  • 2019
  • Ingår i: Heart. - 1355-6037 .- 1468-201X. ; 105:3, s. 235-242
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVES: Compare the effect of apixaban and warfarin on coagulation and primary haemostasis biomarkers in atrial fibrillation (AF).METHODS: The biomarker substudy from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial included 4850 patients with AF randomised to treatment with apixaban or warfarin. Sixty per cent of patients used vitamin K antagonist (VKA) within 7 days before randomisation. Prothrombin fragment 1+2 (F1+2), D-dimer, soluble CD40 ligand (sCD40L) and von Willebrand factor (vWF) antigen were analysed at randomisation and after 2 months of study treatment.RESULTS: In patients not on VKA treatment at randomisation, F1+2 and D-dimer levels were decreased by 25% and 23%, respectively, with apixaban, and by 59% and 38%, respectively, with warfarin (p<0.0001 for treatment differences for both). In patients on VKA at randomisation, F1+2 and D-dimer levels increased by 41% and 10%, respectively, with apixaban and decreased by 37% and 11%, respectively, with warfarin (p<0.0001 for treatment differences for both). sCD40L levels were slightly increased at 2 months, regardless of VKA or randomised treatment. Apixaban and warfarin also both reduced vWF antigen regardless of VKA treatment. The efficacy (stroke) and safety (bleeding) of apixaban compared with warfarin was similar irrespectively of biomarker levels at 2 months.CONCLUSIONS: Treatment with apixaban compared with warfarin for stroke prevention in patients with AF was associated with less reduction in thrombin generation and fibrin turnover. This effect of apixaban could contribute to the clinical results where apixaban was superior to warfarin both in stroke prevention and in reducing bleeding risk.TRIAL REGISTRATION NUMBER: NCT00412984.
  • Collinson, Paul, et al. (författare)
  • Type 2 myocardial infarction : the chimaera of cardiology?
  • 2015
  • Ingår i: Heart. - 1355-6037 .- 1468-201X. ; 101:21, s. 1697-1703
  • Forskningsöversikt (refereegranskat)abstract
    • The term type 2 myocardial infarction first appeared as part of the universal definition of myocardial infarction. It was introduced to cover a group of patients who had elevation of cardiac troponin but did not meet the traditional criteria for acute myocardial infarction although they were considered to have an underlying ischaemic aetiology for the myocardial damage observed. Since first inception, the term type 2 myocardial infarction has always been vague. Although attempts have been made to produce a systematic definition of what constitutes a type 2 myocardial infarction, it has been more often characterised by what it is not rather than what it is. Clinical studies that have used type 2 myocardial infarction as a diagnostic criterion have produced disparate incidence figures. The range of associated clinical conditions differs from study to study. Additionally, there are no agreed or evidence-based treatment strategies for type 2 myocardial infarction. The authors believe that the term type 2 myocardial infarction is confusing and not evidence-based. They consider that there is good reason to stop using this term and consider instead the concept of secondary myocardial injury that relates to the underlying pathophysiology of the primary clinical condition.
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (3693)
recension (149)
forskningsöversikt (75)
konferensbidrag (28)
konstnärligt arbete (1)
annan publikation (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (3405)
övrigt vetenskapligt (533)
populärvet., debatt m.m. (8)
Askling, J (96)
Rönnelid, Johan (49)
Alfredsson, L (47)
Rantapää-Dahlqvist, ... (46)
van Vollenhoven, RF (42)
visa fler...
Bremander, Ann, 1957 ... (38)
Saxne, Tore (38)
Lundberg, IE (37)
Bergman, Stefan, 195 ... (36)
van Vollenhoven, R (36)
Svenungsson, E. (34)
Gunnarsson, I. (33)
Padyukov, L (33)
Rönnblom, Lars (33)
Olsson, T (31)
Geborek, Pierre (30)
Nordmark, Gunnel (30)
Ronnelid, J (30)
Klareskog, Lars (29)
Petersson, Ingemar (29)
Jacobsson, Lennart (26)
Bengtsson, C (26)
Askling, Johan (26)
Gordon, C. (26)
Saevarsdottir, S (25)
Forsblad-d'Elia, Hel ... (24)
Hillert, J (23)
Birgisson, Björn (23)
Isenberg, D (23)
Holmqvist, M (23)
Sturfelt, Gunnar (22)
Ludvigsson, JF (22)
Mariette, X (22)
Schoenhals, Michael (22)
Holmdahl, R (21)
Turesson, Carl (21)
Wahren-Herlenius, M (21)
Neovius, M (21)
Haglund, Emma, 1970- (21)
Rantapaa-Dahlqvist, ... (21)
Martin, J. (20)
Ronnblom, L. (20)
Ramos-Casals, M (20)
Lohmander, Stefan (20)
van der Heijde, D (20)
Frisell, T. (20)
Gunnarsson, Iva (19)
Jonsen, A (19)
Emery, P. (19)
visa färre...
Karolinska Institutet (912)
Lunds universitet (708)
Uppsala universitet (686)
Umeå universitet (385)
Stockholms universitet (373)
Göteborgs universitet (371)
visa fler...
Linköpings universitet (229)
Kungliga Tekniska Högskolan (207)
Örebro universitet (156)
Linnéuniversitetet (87)
Högskolan i Halmstad (73)
Jönköping University (67)
Karlstads universitet (61)
Malmö universitet (60)
Södertörns högskola (52)
Luleå tekniska universitet (49)
Mälardalens högskola (48)
Försvarshögskolan (46)
Mittuniversitetet (41)
Chalmers tekniska högskola (40)
Högskolan Dalarna (33)
Högskolan i Gävle (31)
Högskolan i Borås (29)
VTI - Statens väg- och transportforskningsinstitut (19)
Ersta Sköndal Bräcke högskola (18)
Sveriges Lantbruksuniversitet (13)
Högskolan Kristianstad (12)
Högskolan Väst (12)
Blekinge Tekniska Högskola (12)
RISE (10)
Högskolan i Skövde (9)
Sophiahemmet Högskola (8)
Nordiska Afrikainstitutet (6)
Röda Korsets Högskola (4)
Gymnastik- och idrottshögskolan (3)
Naturhistoriska riksmuseet (1)
visa färre...
Engelska (3940)
Svenska (2)
Kinesiska (2)
Tyska (1)
Ryska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1341)
Samhällsvetenskap (1174)
Teknik (194)
Humaniora (172)
Naturvetenskap (140)
Lantbruksvetenskap (5)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy